{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-221469","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2023-08-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.112353+00:00","generated_at":"2026-06-11T03:34:46.723138+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Celularity enters $3M loan agreement with CEO Hariri and other lenders","bullets":["Loan $3M aggregate from CEO Dr. Robert Hariri ($1M) and two unaffiliated lenders at 15% annual interest.","First-year interest paid in kind monthly; matures August 21, 2024.","Mandatory prepayment upon receiving gross proceeds of $4.5M or more from a subsequent transaction.","Proceeds used for working capital and general corporate purposes.","Customary negative covenants include restrictions on additional indebtedness and liens."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-221469","json":"https://secwatch.observer/filing/0001193125-23-221469.json","markdown":"https://secwatch.observer/filing/0001193125-23-221469.md","text":"https://secwatch.observer/filing/0001193125-23-221469.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523221469/0001193125-23-221469-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523221469/d531828d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T03:34:46.723138+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e4f6bba86d81b07b24df7f51a8002849fa0142dd","claim":"Celularity Inc incurred loan of $3.0 million with Dr. Robert Hariri and two unaffiliated lenders at 15% per year maturing August 21, 2024.","evidence_excerpt":"On August 21, 2023, Celularity Inc., or Celularity, entered into a Loan Agreement with its Chairman and Chief Executive Officer, Dr. Robert Hariri, and two unaffiliated lenders, providing for a loan in the aggregate principal amount of $3.0 million (of which Dr. Hariri contributed $1.0 million), or the Loan.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523221469/0001193125-23-221469-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$3.0 million"},{"label":"Counterparty","value":"Dr. Robert Hariri and two unaffiliated lenders"},{"label":"Rate","value":"15% per year"},{"label":"Maturity","value":"August 21, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"6a8f95217a7e06a50703de33eebcb7adf53218eb","claim":"Celularity Inc entered into Loan Agreement with Dr. Robert Hariri and two unaffiliated lenders valued at $3.0 million (effective 2023-08-21).","evidence_excerpt":"On August 21, 2023, Celularity Inc., or Celularity, entered into a Loan Agreement with its Chairman and Chief Executive Officer, Dr. Robert Hariri, and two unaffiliated lenders, providing for a loan in the aggregate principal amount of $3.0 million","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523221469/0001193125-23-221469-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Dr. Robert Hariri and two unaffiliated lenders"},{"label":"Value","value":"$3.0 million"},{"label":"Effective","value":"2023-08-21"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}